Journal of the American Society of Hypertension
Volume 2, Issue 5 , Pages 318-325 , September 2008

Oxytocin revisited: It is also a cardiovascular hormone

  • Jolanta Gutkowska, PhD

      Affiliations

    • Corresponding Author InformationCorresponding author: Jolanta Gutkowska, PhD, Laboratory of Cardiovascular Biochemistry, Research Centre, CHUM—Hôtel-Dieu, 3850 St. Urbain Street, Masson Pavilion, Montreal, Quebec, Canada H2W 1T7. Tel: 514-890-8000 (ext. 2731); fax: 514-412-7204
    • ,
  • Marek Jankowski, PhD

Received 14 February 2008 ,Accepted 17 April 2008.

References 

  1. Nishimori K, Young LJ, Guo Q, Wang Z, Insel TR, Matzuk MM. Oxytocin is required for nursing but is not essential for parturition or reproductive behavior. Proc Natl Acad Sci U S A. 1996;93:11699–11704
  2. Gimpl G, Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol Rev. 2001;81:629–683
  3. Uvnas-Moberg K, Petersson M. [Oxytocin, a mediator of anti-stress, well-being, social interaction, growth and healing]. Z Psychosom Med Psychother. 2005;51:57–80
  4. Paquin J, Danalache BA, Jankowski M, McCann SM, Gutkowska J. Oxytocin induces differentiation of P19 embryonic stem cells to cardiomyocytes. Proc Natl Acad Sci U S A. 2002;99:9550–9555
  5. Jankowski M, Danalache B, Wang D, Bhat P, Hajjar F, Marcinkiewicz M, et al. Oxytocin in cardiac ontogeny. Proc Natl Acad Sci U S A. 2004;101:13074–13079
  6. Soares TJ, Coimbra TM, Martins AR, Pereira AG, Carnio EC, Branco LG, et al. Atrial natriuretic peptide and oxytocin induce natriuresis by release of cGMP. Proc Natl Acad Sci U S A. 1999;96:278–283
  7. Petty MA, Lang RE, Unger T, Ganten D. The cardiovascular effects of oxytocin in conscious male rats. Eur J Pharmacol. 1985;112:203–210
  8. Favaretto AL, Ballejo GO, Albuquerque-Araujo WI, Gutkowska J, Antunes-Rodrigues J, McCann SM. Oxytocin releases atrial natriuretic peptide from rat atria in vitro that exerts negative inotropic and chronotropic action. Peptides. 1997;18:1377–1381
  9. Mukaddam-Daher S, Lin YL, Gutkowska J, Cardinal R. Negative inotropic and chronotropic effects of oxytocin. Hypertension. 2001;38:292–296
  10. Thibonnier M, Conarty DM, Preston JA, Plesnicher CL, Dweik RA, Erzurum S. Human vascular endothelial cells express oxytocin receptors. Endocrinology. 1999;140:1301–1309
  11. Biyikli NK, Tugtepe H, Sener G, Velioglu-Ogunc A, Cetinel S, Midillioglu S, et al. Oxytocin alleviates oxidative renal injury in pyelonephritic rats via a neutrophil-dependent mechanism. Peptides. 2006;
  12. Iseri SO, Sener G, Saglam B, Gedik N, Ercan F, Yegen BC. Oxytocin ameliorates oxidative colonic inflammation by a neutrophil-dependent mechanism. Peptides. 2005;26:483–491
  13. Altszuler N, Rosenberg CR, Winkler B, Fuchs AR, Hill PS, Hruby VJ. The metabolic effects of oxytocin are mediated by a uterine type of receptor and are inhibited by oxytocin antagonist and by arginine vasopressin in the dog. Life Sci. 1992;50:739–746
  14. Land H, Grez M, Ruppert S, Schmale H, Rehbein M, Richter D, et al. Deduced amino acid sequence from the bovine oxytocin-neurophysin I precursor cDNA. Nature. 1983;302:342–344
  15. Hara Y, Battey J, Gainer H. Structure of mouse vasopressin and oxytocin genes. Brain Res Mol Brain Res. 1990;8:319–324
  16. Jirikowski GF, Back H, Forssmann WG, Stumpf WE. Coexistence of atrial natriuretic factor (ANF) and oxytocin in neurons of the rat hypothalamus. Neuropeptides. 1986;8:243–249
  17. Baldissera S, Menani JW, Sotero dos Santos LF, Favaretto AL, Gutkowska J, Turrin MQ, et al. Role of the hypothalamus in the control of atrial natriuretic peptide release. Proc Natl Acad Sci U S A. 1989;86:9621–9625
  18. Antunes-Rodrigues J, Ramalho MJ, Reis LC, Menani JV, Turrin MQ, Gutkowska J, et al. Lesions of the hypothalamus and pituitary inhibit volume-expansion-induced release of atrial natriuretic peptide. Proc Natl Acad Sci U S A. 1991;88:2956–2960
  19. Haanwinckel MA, Elias LK, Favaretto AL, Gutkowska J, McCann SM, Antunes-Rodrigues J. Oxytocin mediates atrial natriuretic peptide release and natriuresis after volume expansion in the rat. Proc Natl Acad Sci U S A. 1995;92:7902–7906
  20. Conrad KP, Gellai M, North WG, Valtin H. Influence of oxytocin on renal hemodynamics and electrolyte and water excretion. Am J Physiol. 1986;251:F290–F296
  21. Inoue T, Naruse M, Nakayama M, Kurokawa K, Sato T. Oxytocin affects apical sodium conductance in rabbit cortical collecting duct. Am J Physiol. 1993;265:F487–F503
  22. Verbalis JG, Mangione MP, Stricker EM. Oxytocin produces natriuresis in rats at physiological plasma concentrations. Endocrinology. 1991;128:1317–1322
  23. Sedlakova E, Lichardus B, Cort JH. Plasma saluretic activity: its nature and relation to oxytocin analogs. Science. 1969;164:580–582
  24. Gutkowska J, Nemer M. Structure, expression, and function of atrial natriuretic factor in extraatrial tissues. Endocr Rev. 1989;10:519–536
  25. Nakano J, Fisher RD. Studies on the cardiovascular effects of synthetic oxytocin. [abstract] J Pharmacol Exp Ther. 1963;142:206
  26. Woodbury RA, Hamilton WF, Volpitto PP, Abreu BE, Harper HT. Cardiac and blood pressure effects of pitocin (oxytocin) in man. J Pharmacol. 1944;81:95–100
  27. Petersson M, Alster P, Lundeberg T, Uvnas-Moberg K. Oxytocin causes a long-term decrease of blood pressure in female and male rats. Physiol Behav. 1996;60:1311–1315
  28. Bernatova I, Rigatto KV, Key MP, Morris M. Stress-induced pressor and corticosterone responses in oxytocin-deficient mice. Exp Physiol. 2004;89:549–557
  29. Michelini LC, Marcelo MC, Amico J, Morris M. Oxytocinergic regulation of cardiovascular function: studies in oxytocin-deficient mice. Am J Physiol Heart Circ Physiol. 2003;284:H2269–H2276
  30. Light KC, Grewen KM, Amico JA, Brownley KA, West SG, Hinderliter AL, et al. Oxytocinergic activity is linked to lower blood pressure and vascular resistance during stress in postmenopausal women on estrogen replacement. Horm Behav. 2005;47:540–548
  31. Light KC, Grewen KM, Amico JA. More frequent partner hugs and higher oxytocin levels are linked to lower blood pressure and heart rate in premenopausal women. Biol Psychol. 2005;69:5–21
  32. Gutkowska J, Jankowski M, Lambert C, Mukaddam-Daher S, Zingg HH, McCann S. Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart. Proc Natl Acad Sci U S A. 1997;94:11704–11709
  33. Dietz JR. Mechanisms of atrial natriuretic peptide secretion from the atrium. Cardiovasc Res. 2005;68:8–17
  34. Ruskoaho H. Atrial natriuretic peptide: synthesis, release, and metabolism. Pharmacol Rev. 1992;44:479–602
  35. Maack T. The broad homeostatic role of natriuretic peptides. Arq Bras Endocrinol Metabol. 2006;50:198–207
  36. Zingg HH, Rozen F, Breton C, Larcher A, Neculcea J, Chu K, et al. Gonadal steroid regulation of oxytocin and oxytocin receptor gene expression. Adv Exp Med Biol. 1995;395:395–404
  37. Gutkowska J, Paquette A, Wang D, Lavoie JM, Jankowski M. Effect of exercise training on cardiac oxytocin and natriuretic peptide systems in ovariectomized rats. Am J Physiol Regul Integr Comp Physiol. 2007;293:R267–R275
  38. Bakos J, Hlavacova N, Makatsori A, Tybitanclova K, Zorad S, Hinghofer-Szalkay H, et al. Oxytocin levels in the posterior pituitary and in the heart are modified by voluntary wheel running. Regul Pept. 2007;139:96–101
  39. Jankowski M, Wang D, Hajjar F, Mukaddam-Daher S, McCann SM, Gutkowska J. Oxytocin and its receptors are synthesized in the rat vasculature. Proc Natl Acad Sci U S A. 2000;97:6207–6211
  40. Jankowski M, Hajjar F, Al Kawas S, Mukaddam-Daher S, Hoffman G, McCann SM, et al. Rat heart: a site of oxytocin production and action. Proc Natl Acad Sci U S A. 1998;95:14558–14563
  41. Ragnauth AK, Goodwillie A, Brewer C, Muglia LJ, Pfaff DW, Kow LM. Vasopressin stimulates ventromedial hypothalamic neurons via oxytocin receptors in oxytocin gene knockout male and female mice. Neuroendocrinology. 2004;80:92–99
  42. Gassanov N, Jankowski M, Danalache B, Wang D, Grygorczyk R, Hoppe UC, et al. Arginine vasopressin-mediated cardiac differentiation: insights into the role of its receptors and nitric oxide signaling. J Biol Chem. 2007;282:11255–11265
  43. Gassanov N, Devost D, Danalache B, Noiseux N, Jankowski M, Zingg HH, et al. Functional activity of the carboxyl-terminally extended oxytocin precursor peptide during cardiac differentiation of embryonic stem cells. Stem Cells. 2008;26:45–54
  44. Zingg HH, Laporte SA. The oxytocin receptor. Trends Endocrinol Metab. 2003;14:222–227
  45. Holmes CL, Landry DW, Granton JT. Science review: vasopressin and the cardiovascular system part 2 — clinical physiology. Crit Care. 2004;8:15–23
  46. Danalache BA, Paquin J, Donghao W, Grygorczyk R, Moore JC, Mummery CL, et al. Nitric oxide signaling in oxytocin-mediated cardiomyogenesis. Stem Cells. 2007;25:679–688
  47. Oyama T, Nagai T, Wada H, Naito AT, Matsuura K, Iwanaga K, et al. Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo. J Cell Biol. 2007;176:329–341
  48. Matsuura K, Nagai T, Nishigaki N, Oyama T, Nishi J, Wada H, et al. Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J Biol Chem. 2004;279:11384–11391
  49. Wang X, Hu Q, Nakamura Y, Lee J, Zhang G, From AH, et al. The role of the sca-1+/−. Stem Cells. 2006;24:1779–1788
  50. Altstein M, Gainer H. Differential biosynthesis and posttranslational processing of vasopressin and oxytocin in rat brain during embryonic and postnatal development. J Neurosci. 2007;8:3967–3977

 This work was supported by the Canadian Institute of Health Research (CIHR, MOP-53217) and the Canadian Heart and Stroke Foundation (CHSF, NET Program) as Grants to Drs. Gutkowska and Jankowski. Lecture presented In Memoriam to Professor S.M. McCann at the International Symposium on Vasoactive Peptides, Ouro Preto, Brazil, February 14 to 16, 2008.

 Conflict of interest: none.

PII: S1933-1711(08)00049-1

doi: 10.1016/j.jash.2008.04.004

Journal of the American Society of Hypertension
Volume 2, Issue 5 , Pages 318-325 , September 2008

Article Tools

* Image Usage & Resolution